A review on triple-negative breast cancer and its potential treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| 1. autor: | |
|---|---|
| Kolejni autorzy: | |
| Format: | Praca dyplomowa |
| Język: | English |
| Wydane: |
Brac University
2023
|
| Hasła przedmiotowe: | |
| Dostęp online: | http://hdl.handle.net/10361/17766 |
| id |
10361-17766 |
|---|---|
| record_format |
dspace |
| spelling |
10361-177662023-01-18T21:01:49Z A review on triple-negative breast cancer and its potential treatment Niasa, Jannatul Ferdous Chowdhury, Namara Mariam Department of Pharmacy, Brac University TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast--Cancer--Patients Breast--Cancer--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. Cataloged from PDF version of thesis. Includes bibliographical references (pages 41-45). Triple-negative breast cancer is defined as breast cancer that lacks estrogen, progesterone, and the human epidermal growth factor receptor 2. (TNBC). This malignancy accounts for 15–20 percent of all breast cancers and is of particular interest for study because of its clinically problematic low treatment response and highly invasive features. Due to the lack of particular treatment options for TNBC, conventional therapy such as adjuvant and neoadjuvant therapy, surgery, immunotherapy, and radiation therapy are frequently used. The focus of this review is to provide information related to TNBC diagnosis and survival rate, biomarkers, different signaling pathways as well as current and investigation therapies, prognosis, and some advanced research about drugs and therapies. Researchers working in the area may find the data offered in this publication useful in obtaining general and specific information to increase their understanding of TNBC and provide appropriate disease management in the future. Jannatul Ferdous Niasa Jannatul Ferdous Niasa B. Pharmacy 2023-01-18T10:00:47Z 2023-01-18T10:00:47Z 2022 2022-05 Thesis ID 18146073 http://hdl.handle.net/10361/17766 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 45 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast--Cancer--Patients Breast--Cancer--Treatment |
| spellingShingle |
TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast--Cancer--Patients Breast--Cancer--Treatment Niasa, Jannatul Ferdous A review on triple-negative breast cancer and its potential treatment |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. |
| author2 |
Chowdhury, Namara Mariam |
| author_facet |
Chowdhury, Namara Mariam Niasa, Jannatul Ferdous |
| format |
Thesis |
| author |
Niasa, Jannatul Ferdous |
| author_sort |
Niasa, Jannatul Ferdous |
| title |
A review on triple-negative breast cancer and its potential treatment |
| title_short |
A review on triple-negative breast cancer and its potential treatment |
| title_full |
A review on triple-negative breast cancer and its potential treatment |
| title_fullStr |
A review on triple-negative breast cancer and its potential treatment |
| title_full_unstemmed |
A review on triple-negative breast cancer and its potential treatment |
| title_sort |
review on triple-negative breast cancer and its potential treatment |
| publisher |
Brac University |
| publishDate |
2023 |
| url |
http://hdl.handle.net/10361/17766 |
| work_keys_str_mv |
AT niasajannatulferdous areviewontriplenegativebreastcanceranditspotentialtreatment AT niasajannatulferdous reviewontriplenegativebreastcanceranditspotentialtreatment |
| _version_ |
1814307277184696320 |